Cervical intraepithelial neoplasia in women who had vaccination against HPV
- 8 August 2019
- journal article
- research article
- Published by Wiley in International Journal of Gynecology & Obstetrics
- Vol. 147 (2) , 233-237
Abstract
Objective: To investigate the characteristics of women developing cervical intraepithelial neoplasia who had had a vaccination against human papillomavirus (HPV).Methods: A retrospective cohort study was carried out of women diagnosed with moderate or severe cervical dysplasia (CIN2+) in four Italian centers between 2015 and 2017. All women included had had previous bivalent or quadrivalent vaccination against HPV.Results: The present study included 43 patients affected by CIN2+. The median age was 28 (range, 21–41) years. Ten (23.3%) patients did not have a diagnosis of specific HPV type(s) involved: high‐risk HPV was detected in 7 (16.3%) women while HPV testing was negative in 3 (6.9%) women. Lesions related to HPV16 were found in two patients. HPV types covered by nonavalent vaccination were diagnosed in 27/33 (81.8%) women. HPV types not covered by nonavalent vaccination were diagnosed in 6 (18.2%) women. Co‐infections are most commonly detected in women with HPVs other than those included in the nonavalent vaccination (P=0.024).Conclusion: Cervical dysplasia occurring after HPV vaccination is a rare condition. Theoretically, nonavalent vaccination should improve protection against more than 80% of HPV‐related lesions compared to other vaccines.Keywords
This publication has 13 references indexed in Scilit:
- Artificial intelligence estimates the impact of human papillomavirus types in influencing the risk of cervical dysplasia recurrence: progress toward a more personalized approachEuropean Journal Of Cancer Prevention, 2019
- Predicting Factors for High-Grade Cervical Dysplasia in Women With Low-Grade Cervical Cytology and Nonvisible Squamocolumnar JunctionReproductive Sciences, 2019
- The role of human papillomavirus vaccines in cervical cancer: Prevention and treatmentCritical Reviews in Oncology/Hematology, 2018
- Test Characteristics of Specific p16 Clones in the Detection of High-grade Squamous Intraepithelial Lesions (HSIL)International Journal of Gynecological Pathology, 2018
- Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trialPLOS Medicine, 2017
- Retrospective study of the influence of HPV persistence on outcomes among women with high‐risk HPV infections and negative cytologyInternational Journal of Gynecology & Obstetrics, 2017
- Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 7-year follow-up of the phase 3, double-blind, randomised controlled VIVIANE studyThe Lancet Infectious Diseases, 2016
- Sexually Transmitted Infections Among US Women and MenSexually Transmitted Diseases, 2013
- Persistent Human Papillomavirus Infection and Cervical Neoplasia: A Systematic Review and Meta-AnalysisAmerican Journal of Epidemiology, 2008
- Carcinogenicity of human papillomavirusesThe Lancet Oncology, 2005